Patient-reported adverse drug reactions and drug-drug interactions: A cross-sectional study on Malaysian HIV/AIDS patients

Medical Principles and Practice

Volumn 20, Issue 3, 2011, Pages 265-270

  Hasan, Syed S ^a   Keong, See C ^a   Choong, Christopher L K ^b   Ahmed, Syed I ^a   Ching, Ting W ^b   Anwar, Mudassir ^a   Ahmadi, Keivan ^a   Babar, Muneer G ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b HOSPITAL SUNGAI BULOH   (Malaysia)

Author keywords

Drug drug interactions; HIV AIDS; Malaysians; Patient reported adverse drug reactions

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHLORPHENIRAMINE; COTRIMOXAZOLE; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; GEMFIBROZIL; INDINAVIR; ITRACONAZOLE; LAMIVUDINE; NEVIRAPINE; PRAVASTATIN; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVERSE DRUG REACTION; AGE; AIDS PATIENT; ALLERGIC REACTION; ALTERNATIVE MEDICINE; AMNESIA; ANOREXIA; ANTIVIRAL THERAPY; ARTICLE; COLD SWEAT; COMBINATION CHEMOTHERAPY; CROSS-SECTIONAL STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; NAUSEA AND VOMITING; NIGHTMARE; PRESCRIPTION; SELF REPORT; SENSORY DYSFUNCTION; SEX DIFFERENCE; SIDE EFFECT; STOMACH PAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; ADULT; AGE FACTORS; ANTIVIRAL AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG TOXICITY; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALAYSIA; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 79953670080     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321274     Document Type: Article

References (32)

1. Joint United Nations Programme on HIV/ AIDS (UNAIDS). UNAIDS annual report. 2007. http://data.unaids.org/pub/Report/2008/jc1535-annual-report07-en. pdf (accessed August 14, 2009).
2. Josephs JS, Fleishman JA, Gaist P, Gebo KA: Use of complementary and alternative medicines (CAM) among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med 2007; 8: 300-305. (Pubitemid 46901529)
3. Mokhtar N, Chan SC: Use of complementary medicine amongst asthmatic patients in primary care. Med J Malaysia 2006; 61: 125-127. (Pubitemid 43667262)
4. Remli R, Chan SC: Use of complementary medicine in systemic lupus erythematosus patients in Malaysia. APLAR J Rheumatol 2003; 6: 21-25.
5. Palella FJ, Delaney KM, Moorman AC, Loveless MO: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860. (Pubitemid 28135961)
6. Nachega JB, Trotta MP, Nelson M, Ammassari A: Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV/ AIDS Rep 2009; 6: 121-129.
7. Minzi OMS, Irunde H, Moshiro C: HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania. Tanzan J Health Res 2009; 11: 5-10.
8. Knobel H, Guelar A, Montero M, Carmona A, Luque S, Gonzalez A: Risk of side effects associated with the use of nevirapine in treatment-naíve patients, with respect to gender and CD4 cell count. HIV Med 2008; 9: 14-18.
9. Taha TE, Kumwenda N, Kafulafula G, Kumwenda J, Chitale R, Nkhoma C: Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth. Ann Trop Paediatr 2004; 34: 301-309. (Pubitemid 40045360)
10. Vigouroux C, Gharakhanian S, Salhi Y, Nguyên TH, Adda N, Rozenbaum W: Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. Diabetes Metab 1999; 25: 383-392.
11. Nuesch R, Srasuebkul P, Ananworanich J, HIV-NAT Study Team: Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand. J Antimicrob Chemother 2006; 58: 637-644. (Pubitemid 44288131)
12. Miller CD, El-Kholi R, Faragon JJ, Lodise TP: Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy 2007; 27: 1319-1386.
13. Robertson SM, Penzak SR, Pau A: Drug interactions in the management of HIV infection: an update. Expert Opin Pharmacother 2007; 8: 2947-2963. (Pubitemid 350300966)
14. Mills E, Ping W, Ernst E: Complementary therapies for the treatment of HIV: in search of the evidence. Int J STD AIDS 2005; 16: 395-402. (Pubitemid 40868373)
15. Piscitelli BC, Burstein AH, Welden N, Gallicano K, Fallon J: Garlic supplement decreases saquinavir plasma concentrations (abstract). Proc 8th Conf Retroviruses Opportunistic Infect, Chicago, February 2001.
16. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Fallon J: Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-548.
17. Peltzer K, Preez NF, Ramlagan S, Fomundam H: Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health 2008; 8: 255.
18. Sharma A, Vora R, Modi M, Sharma A, Marfatia Y: Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol 2008; 74: 234-237. (Pubitemid 351918877)
19. Johnson MO, Stallworth T, Neilands TB: The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav 2003; 7: 109-117. (Pubitemid 36781506)
20. Windi A: Determinants of complementary alternative medicine (CAM) use. Complement Ther Med 2004; 12: 99-111. (Pubitemid 39618836)
21. Malaysian AIDS Council: 2008 Annual Report. 2008. http://www.mac.org.my/ attachment/report2008.pdf (accessed August 15, 2009).
22. Ministry of Health Malaysia, Department of Public Health, Section of AIDS/STD: Summary of HIV/AIDS cases reported by the year 2006. Putrajaya, Ministry of Health Malaysia, 2007.
23. Klassen DL, Kipp W, Jhangri GS, Rubaale T: Use of traditional herbal medicine by AIDS patients in Kabarole District, Western Uganda. Am J Trop Med Hyg 2007; 77: 757-763. (Pubitemid 351844305)
24. Manuthu EM, Joshi MD, Lule GN, Karari E: Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East Afr Med J 2008; 85: 7-10.
25. Makoae LN, Seboni NM, Molosiwa K, Moleko M, Human S, Sukati NA: The symptom experience of people living with HIV/ AIDS in Southern Africa. J Assoc Nurses AIDS Care 2005; 16: 22-32. (Pubitemid 40853637)
26. Christopher Lee KC: The first report of the National HIV/AIDS Treatment Registry 2003. Kuala Lumpur, National HIV/AIDS Treatment Registry, 2005.
27. Bica L, McGovern B, Dhar R, Stone D, McGowan K, Scheib R: Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492-497. (Pubitemid 32173638)
28. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M: Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33: 240-247. (Pubitemid 32643340)
29. Simone MJ, Appelbaum J: HIV in older adults. Geriatrics 2008; 63: 6-12.
30. Yeh YL, Liu HY, Ko WC, Lee HC, Ko NY: HIV related symptoms in patients with HIV infection enrolled in an HIV case management program in Taiwan. J Nursing 2008; 16: 237-245.
31. Standish LJ, Greene KB, Bain S, Reeves C, Sanders F, Wines RCM: Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care 2001; 13: 197-208. (Pubitemid 32319884)
32. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30. (Pubitemid 30432540)